Do we dare to anonymize real-world data?
In the era of digital health transformation, the availability of patient data from hospitals…
Is medical device HTA really a pain?
Health Technology Assessment (HTA) of medical devices is perceived in Europe…
Performance-based managed entry agreements
Managed entry agreements (MEA) are arrangements that address…
Societal perspective in health-economic evaluations
Before any health-economic assessment, it is necessary…
HTA is not scaled for burden of rare diseases
Rare diseases are a group of diverse diseases that affects a small number of people…
Bottlenecks in pharmacotherapy
Ensuring that a newly registered drug reaches as many as possible benefiting…
New world, new strategies?
Face-to-face meetings with doctors have long been the preferred way for pharma…
Overthrow the Red Queen
‘How much investment should marketing make in advancing its capabilities?’ is a fair question.
MENDEL - digitisation of communication between healthcare professionals and health insurance companies
Innovative treatment is often only available upon approval of the application by the medical examiner…